Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
281,594
281,594
202,129
402,710
129,085
Depreciation & amortisation
84,856
84,856
49,641
2,997
3,284
Deferred income taxes
34,506
34,506
40,005
-155,434
0
Stock-based compensation
36,620
36,620
24,397
20,820
17,204
Change in working capital
-38,671
-38,671
-85,951
3,738
-108,366
Accounts receivable
-3,339
-3,339
-83,941
6,755
-38,288
Inventory
-26,884
-26,884
-17,481
7,371
-31,388
Other working capital
373,277
373,277
235,300
297,983
52,950
Other non-cash items
-4,626
-4,626
6,927
22,352
13,603
Net cash provided by operating activities
388,571
388,571
240,110
299,440
55,454
Cash flows from investing activities
Investments in property, plant and equipment
-15,294
-15,294
-4,810
-1,457
-2,504
Acquisitions, net
0
0
-999,120
0
-
Purchases of investments
-292,911
-292,911
-255,208
-652,515
-226,185
Sales/maturities of investments
211,296
211,296
746,127
247,683
305,967
Other investing activities
-
-
26,006
-
-
Net cash used for investing activities
-96,909
-96,909
-487,005
-406,289
78,354
Cash flows from financing activities
Debt repayment
-13,483
-13,483
-447,453
-369,064
-19,560
Common stock repurchased
-402,383
-402,383
-200,002
-350,058
-150,117
Other financing activities
-
-
-76,224
-424
-
Net cash used provided by (used for) financing activities
-407,987
-407,987
362,371
77,865
-106,284
Net change in cash
-116,325
-116,325
115,476
-28,984
27,524
Cash at beginning of period
234,695
234,695
119,219
148,203
120,679
Cash at end of period
118,370
118,370
234,695
119,219
148,203
Free cash flow
Operating cash flow
388,571
388,571
240,110
299,440
55,454
Capital expenditure
-15,294
-15,294
-4,810
-1,457
-2,504
Free cash flow
373,277
373,277
235,300
297,983
52,950
© 2024 Yahoo. All rights reserved.